Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antisense Oligonucleotide
1.2.3 Aptamer
1.2.4 Other
1.3 Market by Application
1.3.1 Global Antisense and RNAi Therapeutics Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neuromuscular Diseases
1.3.3 ATTR
1.3.4 Hepatic VOD
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense and RNAi Therapeutics Drug Market Perspective (2018-2029)
2.2 Antisense and RNAi Therapeutics Drug Growth Trends by Region
2.2.1 Global Antisense and RNAi Therapeutics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antisense and RNAi Therapeutics Drug Historic Market Size by Region (2018-2024)
2.2.3 Antisense and RNAi Therapeutics Drug Forecasted Market Size by Region (2024-2029)
2.3 Antisense and RNAi Therapeutics Drug Market Dynamics
2.3.1 Antisense and RNAi Therapeutics Drug Industry Trends
2.3.2 Antisense and RNAi Therapeutics Drug Market Drivers
2.3.3 Antisense and RNAi Therapeutics Drug Market Challenges
2.3.4 Antisense and RNAi Therapeutics Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense and RNAi Therapeutics Drug Players by Revenue
3.1.1 Global Top Antisense and RNAi Therapeutics Drug Players by Revenue (2018-2024)
3.1.2 Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Players (2018-2024)
3.2 Global Antisense and RNAi Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense and RNAi Therapeutics Drug Revenue
3.4 Global Antisense and RNAi Therapeutics Drug Market Concentration Ratio
3.4.1 Global Antisense and RNAi Therapeutics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Drug Revenue in 2022
3.5 Antisense and RNAi Therapeutics Drug Key Players Head office and Area Served
3.6 Key Players Antisense and RNAi Therapeutics Drug Product Solution and Service
3.7 Date of Enter into Antisense and RNAi Therapeutics Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense and RNAi Therapeutics Drug Breakdown Data by Type
4.1 Global Antisense and RNAi Therapeutics Drug Historic Market Size by Type (2018-2024)
4.2 Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Type (2024-2029)
5 Antisense and RNAi Therapeutics Drug Breakdown Data by Application
5.1 Global Antisense and RNAi Therapeutics Drug Historic Market Size by Application (2018-2024)
5.2 Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antisense and RNAi Therapeutics Drug Market Size (2018-2029)
6.2 North America Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024)
6.4 North America Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense and RNAi Therapeutics Drug Market Size (2018-2029)
7.2 Europe Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024)
7.4 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size (2018-2029)
8.2 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense and RNAi Therapeutics Drug Market Size (2018-2029)
9.2 Latin America Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024)
9.4 Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size (2018-2029)
10.2 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Antisense and RNAi Therapeutics Drug Introduction
11.1.4 Biogen Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.1.5 Biogen Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Detail
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.3.5 Jazz Pharmaceuticals Recent Development
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Detail
11.4.2 Bausch & Lomb Business Overview
11.4.3 Bausch & Lomb Antisense and RNAi Therapeutics Drug Introduction
11.4.4 Bausch & Lomb Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.4.5 Bausch & Lomb Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Detail
11.6.2 Dynavax Technologies Business Overview
11.6.3 Dynavax Technologies Antisense and RNAi Therapeutics Drug Introduction
11.6.4 Dynavax Technologies Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.6.5 Dynavax Technologies Recent Development
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Detail
11.7.2 Kastle therapeutics Business Overview
11.7.3 Kastle therapeutics Antisense and RNAi Therapeutics Drug Introduction
11.7.4 Kastle therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.7.5 Kastle therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antisense Oligonucleotide
Table 3. Key Players of Aptamer
Table 4. Key Players of Other
Table 5. Global Antisense and RNAi Therapeutics Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Antisense and RNAi Therapeutics Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antisense and RNAi Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Antisense and RNAi Therapeutics Drug Market Share by Region (2018-2024)
Table 9. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Antisense and RNAi Therapeutics Drug Market Share by Region (2024-2029)
Table 11. Antisense and RNAi Therapeutics Drug Market Trends
Table 12. Antisense and RNAi Therapeutics Drug Market Drivers
Table 13. Antisense and RNAi Therapeutics Drug Market Challenges
Table 14. Antisense and RNAi Therapeutics Drug Market Restraints
Table 15. Global Antisense and RNAi Therapeutics Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Antisense and RNAi Therapeutics Drug Market Share by Players (2018-2024)
Table 17. Global Top Antisense and RNAi Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics Drug as of 2022)
Table 18. Ranking of Global Top Antisense and RNAi Therapeutics Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Antisense and RNAi Therapeutics Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antisense and RNAi Therapeutics Drug Product Solution and Service
Table 22. Date of Enter into Antisense and RNAi Therapeutics Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antisense and RNAi Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Antisense and RNAi Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Biogen Company Detail
Table 48. Biogen Business Overview
Table 49. Biogen Antisense and RNAi Therapeutics Drug Product
Table 50. Biogen Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 51. Biogen Recent Development
Table 52. Sarepta Therapeutics Company Detail
Table 53. Sarepta Therapeutics Business Overview
Table 54. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product
Table 55. Sarepta Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 56. Sarepta Therapeutics Recent Development
Table 57. Jazz Pharmaceuticals Company Detail
Table 58. Jazz Pharmaceuticals Business Overview
Table 59. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product
Table 60. Jazz Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 61. Jazz Pharmaceuticals Recent Development
Table 62. Bausch & Lomb Company Detail
Table 63. Bausch & Lomb Business Overview
Table 64. Bausch & Lomb Antisense and RNAi Therapeutics Drug Product
Table 65. Bausch & Lomb Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 66. Bausch & Lomb Recent Development
Table 67. Alnylam Pharmaceuticals Company Detail
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product
Table 70. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Development
Table 72. Dynavax Technologies Company Detail
Table 73. Dynavax Technologies Business Overview
Table 74. Dynavax Technologies Antisense and RNAi Therapeutics Drug Product
Table 75. Dynavax Technologies Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 76. Dynavax Technologies Recent Development
Table 77. Kastle therapeutics Company Detail
Table 78. Kastle therapeutics Business Overview
Table 79. Kastle therapeutics Antisense and RNAi Therapeutics Drug Product
Table 80. Kastle therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 81. Kastle therapeutics Recent Development
Table 82. Akcea Therapeutics Company Detail
Table 83. Akcea Therapeutics Business Overview
Table 84. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product
Table 85. Akcea Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 86. Akcea Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense and RNAi Therapeutics Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Antisense and RNAi Therapeutics Drug Market Share by Type: 2022 VS 2029
Figure 3. Antisense Oligonucleotide Features
Figure 4. Aptamer Features
Figure 5. Other Features
Figure 6. Global Antisense and RNAi Therapeutics Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Antisense and RNAi Therapeutics Drug Market Share by Application: 2022 VS 2029
Figure 8. Neuromuscular Diseases Case Studies
Figure 9. ATTR Case Studies
Figure 10. Hepatic VOD Case Studies
Figure 11. Other Case Studies
Figure 12. Antisense and RNAi Therapeutics Drug Report Years Considered
Figure 13. Global Antisense and RNAi Therapeutics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Antisense and RNAi Therapeutics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Antisense and RNAi Therapeutics Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Antisense and RNAi Therapeutics Drug Market Share by Players in 2022
Figure 17. Global Top Antisense and RNAi Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antisense and RNAi Therapeutics Drug Revenue in 2022
Figure 19. North America Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Antisense and RNAi Therapeutics Drug Market Share by Country (2018-2029)
Figure 21. United States Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Antisense and RNAi Therapeutics Drug Market Share by Country (2018-2029)
Figure 25. Germany Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Share by Region (2018-2029)
Figure 33. China Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Antisense and RNAi Therapeutics Drug Market Share by Country (2018-2029)
Figure 41. Mexico Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Share by Country (2018-2029)
Figure 45. Turkey Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 49. Jazz Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 50. Bausch & Lomb Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 52. Dynavax Technologies Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 53. Kastle therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed